Research / ITP / Fundamental state Inspectable configuration
State dimensions Filing 0001213900-23-022564 General Corporate
Debt relative to revenue 20th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
9.01% · OPTIONAL · VALID
Capex intensity 50th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
4.52% · OPTIONAL · VALID
Operating cash generation 55th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
10.68% · OPTIONAL · VALID
Revenue growth 10th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
-37.62% · CORE · VALID
Inventory pressure 10th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
2.86% · OPTIONAL · VALID
Gross margin 35th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
4.74% · CORE · VALID
Operating margin 35th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
-5.29% · CORE · VALID
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
0.14% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.16% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 40 states Self-history eligible
Dec 31, 2020 7/9 normalized Amended as filed Mar 31, 2021 7/7 normalized Level 3 Jun 30, 2021 7/7 normalized Level 3 Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/8 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 7/9 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 6/7 normalized Level 3 Mar 31, 2024 6/6 normalized Level 3 Jun 30, 2024 6/6 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/7 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 27.97%
Current 9.01%
Delta -18.96% Capex Intensity Increased
Previous 3.15%
Current 4.52%
Delta 1.36% Cash Generation Decreased
Previous 10.97%
Current 10.68%
Delta -0.29% Growth Decreased
Previous -29.67%
Current -37.62%
Delta -7.95% Inventory Pressure Decreased
Previous 14.01%
Current 2.86%
Delta -11.14% Margin Decreased
Previous 8.78%
Current 4.74%
Delta -4.04% Profitability Decreased
Previous -1.86%
Current -5.29%
Delta -3.43% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.